Cutaneous lupus erythematosus after treatment with paclitaxel and bevacizumab for metastatic breast cancer: a case report

INTRODUCTION: The monoclonal anti-vascular endothelial growth factor antibody bevacizumab is increasingly used in the treatment of several malignant tumors. The usual side effects of this drug are hypertension and proteinuria. Paclitaxel is widely used in the treatment of breast cancer and head and...

Descripción completa

Detalles Bibliográficos
Autores principales: Vihinen, Pia, Paija, Outi, Kivisaari, Atte, Koulu, Leena, Aho, Heikki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143101/
https://www.ncbi.nlm.nih.gov/pubmed/21707979
http://dx.doi.org/10.1186/1752-1947-5-243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143101/
https://www.ncbi.nlm.nih.gov/pubmed/21707979
http://dx.doi.org/10.1186/1752-1947-5-243

Ejemplares similares